← Back to Search

Dietary Supplement

Beetroot Juice for Interstitial Lung Disease

N/A
Waitlist Available
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Clinically stable for the preceding 6 weeks
A multidisciplinary diagnosis of idiopathic pulmonary fibrosis (IPF), idiopathic fibrotic nonspecific interstitial pneumonia (NSIP), chronic hypersensitivity pneumonitis (HP), or unclassifiable ILD with a differential diagnosis that consists of the above diagnoses
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week
Awards & highlights

Study Summary

This trial will test if drinking beetroot juice can help improve exercise performance in people with Interstitial Lung Disease.

Who is the study for?
This trial is for people with certain types of interstitial lung disease (like IPF or NSIP) who have stable oxygen levels and health in the past 6 weeks. They should be able to exercise, not have severe other diseases, no pacemakers or similar devices, and their lung function should be above a specific threshold.Check my eligibility
What is being tested?
The study tests if drinking beetroot juice rich in nitrate improves exercise performance compared to beetroot juice without nitrate for those with interstitial lung disease. Participants will drink one type of juice and see how it affects their ability to exercise.See study design
What are the potential side effects?
Beetroot juice may cause changes in urine color, digestive discomfort, or lower blood pressure. Since it's a natural product used within normal dietary amounts, serious side effects are unlikely but can vary by individual.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My health condition has been stable for the last 6 weeks.
Select...
I have been diagnosed with a specific type of lung scarring disease by a team of doctors.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Difference in submaximal cycle exercise endurance time following dietary nitrate supplementation compared to placebo supplementation.
Secondary outcome measures
Difference in concentration of plasma nitrate ([NO3-]) and nitrite ([NO2-]) following dietary nitrate supplementation compared to placebo supplementation.
Difference in exertional dyspnoea during activities of daily living following dietary nitrate supplementation compared to placebo supplementation.
Difference in exertional dyspnoea during submaximal cycle exercise following dietary nitrate supplementation compared to placebo supplementation.
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Dietary nitrate supplementationExperimental Treatment1 Intervention
The dietary nitrate supplement will be a concentrated, nitrate-rich beetroot juice (70 ml providing ∼400mg nitrate per serving)
Group II: PlaceboPlacebo Group1 Intervention
The placebo will be a concentrated, nitrate-depleted beetroot juice (70 ml with trace amounts of nitrate)

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,407 Previous Clinical Trials
1,766,534 Total Patients Enrolled

Media Library

concentrated beetroot juice (400mg of nitrate per serving) (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT04299945 — N/A
Interstitial Lung Disease Research Study Groups: Dietary nitrate supplementation, Placebo
Interstitial Lung Disease Clinical Trial 2023: concentrated beetroot juice (400mg of nitrate per serving) Highlights & Side Effects. Trial Name: NCT04299945 — N/A
concentrated beetroot juice (400mg of nitrate per serving) (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04299945 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still an opportunity to enlist in this medical experiment?

"As of this moment, the details present on clinicaltrials.gov verify that this study is actively recruiting participants. The initial posting date was January 29th 2020 and it has been recently revised as of May 17th 2022."

Answered by AI

What is the recruitment quota of this trial?

"Correct. According to clinicaltrials.gov, this scientific experiment is actively recruiting participants since its initial listing on January 29th 2020 and the most recent update being made in May 17th 2022. The trial requires 15 individuals across 2 sites for completion."

Answered by AI
~2 spots leftby Dec 2024